MD517G2 - Method of typhoid fever treatment - Google Patents

Method of typhoid fever treatment

Info

Publication number
MD517G2
MD517G2 MD96-0034A MD960034A MD517G2 MD 517 G2 MD517 G2 MD 517G2 MD 960034 A MD960034 A MD 960034A MD 517 G2 MD517 G2 MD 517G2
Authority
MD
Moldova
Prior art keywords
proteins
treatment
correction coefficient
optimal
body mass
Prior art date
Application number
MD96-0034A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD517F1 (en
Inventor
Victor Cojocari
Original Assignee
Cojocaru Victor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of MD517F1 publication Critical patent/MD517F1/en
Publication of MD517G2 publication Critical patent/MD517G2/en
Application filed by Cojocaru Victor filed Critical Cojocaru Victor
Priority to MD96-0034A priority Critical patent/MD517G2/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to the medicine, namely to the therapy and may be used at the treatment of humans having insufficient extremal nutrition conditions.The method consists in the fact that besides medicamental treatment there is realized the enteral proteins hydralyzates administration, by that the complementary nutrition dose is determined on the formula:Bopt=2,07xMopt+2,07xMopt×(Kc+Ks+Kt)(Bh-Bh×Ku),whereBopt - optimal proteins necessity for the patient with the typhoid having body mass dificient (g);2,07 - optimal proteins necessity per 1 kg of body mass in a day of humans having high physical activity before the hospitalisation (g);Mopt - optimal human's body mass (kg);Kt - patients body temperature correction coefficient;Kc -climatic factors correction coefficient;Ks - proteins quantity at the hospital diet (g);Ku - proteins utilization degree correction coefficient.The proposed treatment method has the following technical result: treatment period diminuation; complication and recidives number decreasing in the extremal conditions.
MD96-0034A 1996-12-08 1996-12-08 Method of typhoid fever treatment MD517G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MD96-0034A MD517G2 (en) 1996-12-08 1996-12-08 Method of typhoid fever treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MD96-0034A MD517G2 (en) 1996-12-08 1996-12-08 Method of typhoid fever treatment

Publications (2)

Publication Number Publication Date
MD517F1 MD517F1 (en) 1996-04-30
MD517G2 true MD517G2 (en) 1996-11-30

Family

ID=19738793

Family Applications (1)

Application Number Title Priority Date Filing Date
MD96-0034A MD517G2 (en) 1996-12-08 1996-12-08 Method of typhoid fever treatment

Country Status (1)

Country Link
MD (1) MD517G2 (en)

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Васильев П.С. и др. Сочетанное применение препаратов парентерального белкового питания, энергетических компонентов и стимуляторов биосинтеза белка. Методические рекомендации. М., 1982, р. 30. *
Ляшенко Ю.И., Иванов А.И. Смешанные инфекции, Медицина, М. 1980, р. 81-85. *

Also Published As

Publication number Publication date
MD517F1 (en) 1996-04-30

Similar Documents

Publication Publication Date Title
CA2116559A1 (en) Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
TW265265B (en)
CA2243708A1 (en) Use of lactoperoxidase, a peroxide donor and thiocyanate for the manufacture of a medicament for treating helicobacter pylori infection
CZ176495A3 (en) The use of riluzol for preparing a medicament suitable for treating parkinson's disease and parkinson's syndromes
IE882091L (en) Pharmaceutical compositions comprising sometostatin¹analogues
Bao et al. Twenty-item behavioral neurological assessment for normal newborns in 12 cities of China
NO172043C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE N-2,3-BUTADIENYL-TRIAMIOAL CANDY DERIVATIVES
MY105798A (en) Treatment of leukocyte dysfunction with gm-csf.
West et al. Diagnosis and treatment planning: a coordinated effort between oral and maxillofacial surgery and orthodontics
CN1052403C (en) Quick effect active ion calcium
DE3470002D1 (en) Use of l-fucose in the preparation of an inhalation composition and a process for preparing l-fucose
DE3688787D1 (en) PRODUCTION OF A MEDICINE AGAINST ARTHRITIS AND RHEUMATISM.
CROSS Benign parotid tumors
CN1057001C (en) Chinese medicine capsule for rheumatoid disease
Clifford et al. Occlusal splint prescription in the management of temporomandibular disorders
UA31141A (en) Method for treatment of the allergic states
JPH0722591B2 (en) Magnetic hot heat press health device
CN1122702A (en) Medicine for curing trachitis, asthma and pneumonectasis
RU94016196A (en) Method for treating the cases of abdominal typhoid
CN1065403A (en) Apparatus for treatment of dysmenorrhea
Schutzenberger The drama of seriously ill patient
RICO et al. Harry H., aged eighteen months, was at birth unusually plump and vigorous, and for twelve months thereafter his
ALBERT Temporomandibular Joint Syndrome
de W Kitcat Practical Points in the Home Treatment of Tuberculosis
MARBACH et al. Temporomandibular Joint Syndrome-Reply

Legal Events

Date Code Title Description
FG3A Granted patent for invention
IF99 Valid patent on 19990615

Free format text: EXPIRES: 20161208